Cargando…

Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: A meta-analysis

OBJECTIVE: We conducted a meta-analysis in which the blood pressure (BP)-reducing effect of telmisartan was compared to losartan among hypertensive subjects and its association with ethnicity, age, and gender was investigated. MATERIALS AND METHODS: PubMed, Google Scholar, and the Cochrane library w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumari, Kusum, Toppo, Mary Sunita, Majhi, Lakhan, Kumar, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810954/ https://www.ncbi.nlm.nih.gov/pubmed/36618237 http://dx.doi.org/10.4103/jfmpc.jfmpc_787_22

Ejemplares similares

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Saha, Lekha
Publicado: (2011)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Akat, Pramod B., et al.
Publicado: (2010)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Blood Pressure Reducing Potential and Renoprotective Action of Cilnidipine Among Hypertensive Patients Suffering From Chronic Kidney Disease: A Meta-Analysis
por: Kumari, Kusum, et al.
Publicado: (2023)

Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension
por: Aydoğan, Berna İ, et al.
Publicado: (2019)

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Losartan/Hydrochlorothiazide Fixed Combination Versus Amlodipine Monotherapy in Korean Patients With Mild to Moderate Hypertension
por: Chung, Jin-Wook, et al.
Publicado: (2009)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
por: Lee, Hae-Young, et al.
Publicado: (2017)

Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension
por: Kumar, Prakash, et al.
Publicado: (2016)

Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
por: Graus-Nunes, Francielle, et al.
Publicado: (2019)

Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients
por: Yoo, Yung-Geun, et al.
Publicado: (2023)

The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension
por: Jung, An Doc, et al.
Publicado: (2009)

Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
por: Wang, Ji-Guang, et al.
Publicado: (2014)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension
por: Shimizu, Yuji, et al.
Publicado: (2012)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension
por: Smith, William B., et al.
Publicado: (2012)

Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in Korea
por: Kim, Dae-Hee, et al.
Publicado: (2010)

Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension
por: Zhang, Jian-Qi, et al.
Publicado: (2019)

The Fixed-Dose Combination of Losartan/Hydrochlorothiazide Elicits Potent Blood Pressure Lowering During Nighttime in Obese Hypertensive Patients
por: Ibuki, Chikao, et al.
Publicado: (2014)

Comparative Study of the Effect of Liraglutide and Donepezil on Learning and Memory in Diazepam-Induced Amnesic Albino Rats
por: Kumari, Kusum, et al.
Publicado: (2023)

Telmisartan, when compared to losartan, shows additional beneficial effects to pancreatic islet structure and function in diet-induced obese mice
por: Graus-Nunes, Francielle, et al.
Publicado: (2015)

Functional Vascular Study in Hypertensive Subjects with Type 2 Diabetes Using Losartan or Amlodipine
por: Pozzobon, Cesar Romaro, et al.
Publicado: (2014)

A Review of Telmisartan in the Treatment of Hypertension: Blood Pressure Control in the Early Morning Hours
por: Gosse, Philippe
Publicado: (2006)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
por: Choi, JungMin, et al.
Publicado: (2021)

Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients
por: Kumar, Alok, et al.
Publicado: (2021)

Telmisartan Lowers Elevated Blood Pressure in Psoriatic Mice without Attenuating Vascular Dysfunction and Inflammation
por: Wild, Johannes, et al.
Publicado: (2019)

Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19
por: Rothlin, Rodolfo Pedro, et al.
Publicado: (2023)

Consumption of a Polyphenol-Rich Grape-Wine Extract Lowers Ambulatory Blood Pressure in Mildly Hypertensive Subjects
por: Draijer, Richard, et al.
Publicado: (2015)

Effects of Losartan, Atorvastatin, and Aspirin on Blood Pressure and Gut Microbiota in Spontaneously Hypertensive Rats
por: Dong, Shuai, et al.
Publicado: (2023)

A Case of Moderate Sprue-Like Enteropathy Associated With Telmisartan
por: Negro, Aurelio, et al.
Publicado: (2017)

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension
por: Shin, Mi-Seung, et al.
Publicado: (2016)

Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment
por: Desai, Amit, et al.
Publicado: (2016)

Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
por: Mandraffino, Giuseppe, et al.
Publicado: (2021)

Assessment of Knowledge and Awareness Among Nurses of a Tertiary Care Hospital Regarding the Management of Acute Poisoning: A Cross-Sectional Study
por: Kumari, Kusum, et al.
Publicado: (2023)

Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_a0u62d26bp8omkur6qp0e6ujta